The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety outcomes of darolutamide versus apalutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer (nmCRPC): Matching-adjusted indirect comparisons.
Shan Jiang
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Emi Terasawa
Consulting or Advisory Role - Bayer (Inst)
Viviana Garcia Horton
Consulting or Advisory Role - Bayer (Inst)
Rajeev Ayyagari
Consulting or Advisory Role - Bayer (Inst)
A. Reginald Waldeck
Employment - Bayer
Leadership - Bayer
Stock and Other Ownership Interests - Bayer
Research Funding - Bayer
Travel, Accommodations, Expenses - Bayer
Susan Halabi
Employment - ASCO
Consulting or Advisory Role - Bayer; Eisai; Ferring
Neal D. Shore
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen Scientific Affairs; Medivation/Astellas; Merck; Myovant Sciences; Pfizer; Tolmar
Speakers' Bureau - Bayer; Dendreon; Janssen